Hong Kong Virus Panel Agrees to Lower Vaccination Age to 12


Article content

(Bloomberg) — Hong Kong’s expert advisory panel on Covid vaccinations has agreed to expand eligibility to children as young as 12, according to a person familiar with the matter, as the city works to boost lackluster inoculation rates.

The younger group will be eligible to receive BioNTech SE vaccines, said the person, who asked not to be identified discussing internal plans. Still, the move is subject to final approval by the government, the person added. The recommendation was earlier reported by Cable TV.

Hong Kong’s government said it has received an application about lowering of the age limit for BioNTech vaccines to people as young as 12 and the relevant phase-three clinical trial data from Fosun Pharma, the distributor of BioNTech vaccine in Greater China, according to a statement on Tuesday.

“The Secretary for Food and Health will consider the suggestions by the advisory panel,” it said. “It is expected that a decision on the application for lowering the age limit for vaccination can be reached in short time.”

The government has routinely followed the panel’s vaccine recommendations, usually within days.

That move follows approvals from the U.S. and Canada, paving the way for the mass vaccination of students before the start of the next school year. Singapore also authorized vaccines from Pfizer Inc. and BioNTech SE for children as young as 12 years old earlier in May.

Article content

Hong Kong Chief Executive Carrie Lam announced a campaign on Monday to accelerate the city’s slow inoculation rates by September, with measures such as paid leave for vaccinated civil servants and possible additional restrictions for unvaccinated citizens. The Hong Kong Monetary Authority urged all financial institutions to “strongly encourage” staff in client-facing roles or support functions to get vaccinated.

Read more: Hong Kong Eases Quarantine for Vaccinated Execs, Drawing Ire

Hong Kong is increasingly looking to enlist businesses in the vaccination rollout, which has been impeded by a lack of trust in the Beijing-backed government and concerns about rare side-effects. The government has been ramping up efforts to encourage citizens to receive vaccines by providing policy incentives like reopening bars and shortening the quarantine period for vaccinated people.

Read more: Hong Kong Turns to Businesses to Fix Foundering Vaccine Push

In April, the government opened up vaccines to residents aged 16 and older. People 16 and above are allowed to receive BioNTech vaccines, while those older than 18 can opt for shots made by China’s Sinovac Biotech Ltd. Those under 18 need parental consent to be vaccinated.

©2021 Bloomberg L.P.

Bloomberg.com



Source link

Latest

Delayed monsoon jeopardises India’s economic revival

Delayed monsoon rains are threatening India’s vast agricultural sector and endangering the recovery of an economy reeling from the coronavirus pandemic.Farmers in fertile...

Trump to launch new social media platform Truth Social in SPAC deal

The new Trump company said it was merging with Nasdaq-listed Digital World Acquisition Corp., a blank-check company created to buy another business. The...